Longwood Fund

  • About
  • Portfolio
  • People
  • Press
  • Investor Login
  • Industry Events
  • About
  • Portfolio
  • People
  • Press
  • Investor Login
  • Industry Events

Werewolf Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Highlights

August 12, 2022

TScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress

August 11, 2022

Renovia Receives FDA Clearance for leva® Pelvic Health System as First-line Treatment for Chronic Fecal Incontinence

July 11, 2022

TScan Therapeutics Announces Publication in Cell Highlighting the Discovery of Tumor Antigens and TCRs for the Treatment of Solid Tumors Using Foundational Screening Technology

July 11, 2022

New Clinical Study Demonstrates Colorescience All Calm® Regimen Neutralizes Redness and Calms Inflamed Skin

June 30, 2022

XyloCor Therapeutics Achieves Target Enrollment in Phase 2 EXACT Study of XC001 Novel Gene Therapy for Ischemic Heart Disease

June 30, 2022
« Older Entries

Longwood Fund

The Prudential Tower

800 Boylston Street
Suite 1555
Boston, MA, 02199

  • About
  • Portfolio
  • People
  • Press
  • Investor Login
  • Industry Events

© Longwood Fund. All Rights Reserved